跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VAXAR PLUS 30 MG/10 MG COMPRIMIDOS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VAXAR PLUS 30 MG/10 MG COMPRIMIDOS
Approved
STANDARD
VAXAR PLUS 30 MG/10 MG COMPRIMIDOS
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 29, 2024
Approval ID
c2a838a9d7202b3e
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
c2a838a9d7202b3e
Drug Cima Aemps Name
VAXAR PLUS 30 MG/10 MG COMPRIMIDOS
Register Number
89603
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2024-05-29
Dosage Form
COMPRIMIDO
Dose
30 mg/10 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
ROSUVASTATINA CALCICA
31,20 mg
EZETIMIBA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 29, 2024
Approval ID
c2a838a9d7202b3e
Type
Standard
Back to CIMA-AEMPS Approvals